A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Clinical trial NCT07664553 · RECRUITING
Trial details
- NCT number
- NCT07664553
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-08
- Primary completion
- 2028-05-23
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.